Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Transplant Proc ; 54(10): 2646-2651, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36400591

ABSTRACT

BACKGROUND: The efficacy of the response to SARS-CoV-2 vaccination in kidney transplant recipients is low. The aim of our study was to evaluate the risk factors correlated with the low antibody response and whether there was an improvement between the second and the third dose. METHODS: A prospective study was conducted on 176 kidney transplant recipients who received the second and the third dose of the anti-SARS-CoV-2 mRNA Comirnaty vaccine. We evaluated the seroconversion process after administration of the second and the third dose and assessed a possible correlation with age, time between transplant and vaccination, and type of immunosuppressive therapy. RESULTS: A total of 98 of the 176 patients (55.7%) responded positively after the inoculation of the second dose and according to the multivariable logistic regression analysis the lack of seroconversion was independently associated with patient age ≥60 (P = .025; odds ratio [OR], 2.094), time since transplant of 1 to 3 months (P = .032; OR, 2.118), and triple therapy (P = .044; OR, 2.327). After the vaccine third dose, the seroconversion increased to 62.5%, and it was negatively influenced by calcineurin inhibitor use (12/21, 57.1% vs 71/78, 91.0%, P = .0006) and triple therapy (13/21, 61.9% vs 72/78, 92.3%, P = .0014). The median of antispike antibody response significantly increased from 18.5 IU/mL after the second dose to 316.9 IU after the third dose (P < .0001). CONCLUSIONS: We demonstrated a correlation between older age and shorter distance from the transplant and triple immunosuppressive therapy with the lack of seroconversion. We noticed a significant improvement in antibody response by a third dose of messenger RNA vaccine.


Subject(s)
COVID-19 Vaccines , COVID-19 , Kidney Transplantation , Humans , Antibodies, Viral , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Immunity , Prospective Studies , Risk Factors , RNA, Messenger , SARS-CoV-2 , Transplant Recipients
2.
Curr Biol ; 15(12): 1099-107, 2005 Jun 21.
Article in English | MEDLINE | ID: mdl-15964274

ABSTRACT

BACKGROUND: The visual system is now known to be composed of image-forming and non-image-forming pathways. Photoreception for the image-forming pathway begins at the rods and cones, whereas that for the non-image-forming pathway also involves intrinsically photosensitive retinal ganglion cells (ipRGCs), which express the photopigment melanopsin. In the mouse retina, the rod and cone photoreceptors become light responsive from postnatal day 10 (P10); however, the development of photosensitivity of the ipRGCs remains largely unexplored. RESULTS: Here, we provide direct physiological evidence that the ipRGCs are light responsive from birth (P0) and that this photosensitivity requires melanopsin expression. Interestingly, the number of ipRGCs at P0 is over five times that in the adult retina, reflecting an initial overproduction of melanopsin-expressing cells during development. Even at P0, the ipRGCs form functional connections with the suprachiasmatic nucleus, as assessed by light-induced Fos expression. CONCLUSIONS: The findings suggest that the non-image-forming pathway is functional long before the mainstream image-forming pathway during development.


Subject(s)
Retina/physiology , Retinal Ganglion Cells/physiology , Rod Opsins/metabolism , Animals , Animals, Newborn , Cell Communication/genetics , In Vitro Techniques , Kinetics , Light , Light Signal Transduction/physiology , Mice , Mice, Inbred Strains , Mice, Knockout , Oncogene Proteins v-fos/metabolism , Retina/cytology , Retinal Ganglion Cells/metabolism , Rod Opsins/genetics , Suprachiasmatic Nucleus/growth & development , Suprachiasmatic Nucleus/metabolism
3.
J Biol Rhythms ; 17(2): 121-36, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12002159

ABSTRACT

The induction of the proto-oncogene c-fos, and its phosphoprotein product Fos, has been extensively used to study the effects of light on the circadian pacemaker in the suprachiasmatic nucleus (SCN). Experimental approaches to the quantification of Fos induction have mainly been based on immunohistochemistry and subsequent measure of Fos immunoreactivity (IR) in sections of the SCN. In this study, the authors compare several methods of quantification using optical density image analysis or counts of Fos-IR labeled cells. To assess whether optical density measures using image analysis reflect the amount of Fos in brain tissue, the authors developed standards of known concentrations of Fos protein in an agar matrix. The agar standards were sectioned and treated simultaneously with sections of the SCN from animals exposed to different levels of irradiance. Optical density was found to be proportional to the quantity of Fos in the sections, indicating that this measure accurately reflects relative levels of Fos protein induction. Quantification by optical density analysis allows an objective measure in which the various parameters, conditions of illumination, and threshold can be maintained constant throughout the analysis. Counting cells by visual observation is more subjective because threshold values cannot be precisely defined and can vary according to the observer, illumination, degree of label, and other factors. In addition, cell counts involving direct visual observation, automated cell counts, or stereological methods do not take into account the difference in the density of label between cells, thus giving equal weight to lightly or densely stained cells. These measures are more or less weakly correlated with measures of optical density and thus do not accurately reflect the amount of bound Fos protein in the tissue sections. In contrast, labeled surface area as measured by image analysis shows a linear relationship with optical density. The main outcome of this study is that computer-assisted image analysis provides an accurate and rapid method to determine the relative amount of Fos protein in the SCN and the effects of light on intracellular signaling mechanisms involved in the circadian clock.


Subject(s)
Immunohistochemistry/methods , Oncogene Proteins v-fos/metabolism , Suprachiasmatic Nucleus/metabolism , 3,3'-Diaminobenzidine , Agar , Animals , Avidin , Biotin , Cell Count , Coloring Agents , Image Interpretation, Computer-Assisted , Immunoenzyme Techniques , Male , Mice , Mice, Inbred C3H , Oncogene Proteins v-fos/chemistry , Photic Stimulation , Reference Standards , Suprachiasmatic Nucleus/chemistry , Surface Properties
4.
Behav Brain Res ; 125(1-2): 97-102, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11682100

ABSTRACT

The endogenous circadian clock of mammals retains synchrony with the external light:dark cycle through ocular photoreceptors. To date the identity of the photoreceptors responsible for mediating this response is unknown. This review outlines attempts using transgenic mouse models to address this deficit. Mice bearing specific inherited lesions of both rod and cone photoreceptors retain circadian photosensitivity as assessed by photoentrainment of behavioural rhythms and the light-induced suppression of pineal melatonin. These findings indicate that as yet unidentified non-rod, non-cone ocular photoreceptors are capable of contributing to circadian light responses. Nevertheless, the possibility that circadian photosensitivity is the responsibility of multiple photoreceptor classes including both rod/cone and novel photopigments remains. There is some indirect evidence in favour of this hypothesis. A definitive resolution of this issue is likely to employ comparisons of circadian action spectra in wild type and retinally degenerate mice.


Subject(s)
Circadian Rhythm/genetics , Phenotype , Photoreceptor Cells/physiology , Retinal Degeneration/genetics , Animals , Melatonin/blood , Mice , Mice, Transgenic , Pineal Gland/physiology , Retinal Pigments/genetics , Suprachiasmatic Nucleus/physiology
5.
Neuroscience ; 89(2): 363-74, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10077319

ABSTRACT

The impact of photoreceptor loss on the circadian system was examined by utilizing a transgenic mouse model (rdta) in which rod photoreceptors were specifically ablated. These mice were able to phase-shift their circadian locomotor behaviour in response to light, but features of this circadian behaviour were markedly altered. The amplitude of circadian responses to light were approximately 2.5 greater, the circadian period (tau) was reduced (c. 20 min) and the total duration of activity (alpha) was increased (c. 50 min) when compared to wild type (+/+) and rd/rd mice (retinal degeneration, mice which also lack rod photoreceptors) of the same genetic background. The pattern of Fos expression in the suprachiasmatic nuclei (the site of the primary circadian clock in mammals) was indistinguishable between +/+ and rdta mice. However, Fos expression in the retina suggested that rod loss in rdta mice resulted in a functional reorganization of the retina and the constitutive activation of a population of retinal ganglion cells. Although it has been known for several years that the entraining photoreceptors of mammals are ocular, and that rod photoreceptors are not required for light regulation of the clock, these are the first data to show that features of the circadian phenotype (amplitude of the phase response curve, alpha, tau) can be influenced by photoreceptor ablation. These data support the hypothesis that the circadian phenotype of mammals is the product of an interaction between the suprachiasmatic nuclei and the retina. Thus, mammals which show an altered circadian behaviour can no longer be assumed to have defects associated only with specific clock genes; genes that affect photoreceptor survival may also modify circadian behaviour.


Subject(s)
Circadian Rhythm/physiology , Mice, Transgenic/physiology , Retinal Rod Photoreceptor Cells/physiology , Animals , Circadian Rhythm/radiation effects , Geniculate Bodies/metabolism , Immunohistochemistry , Light , Mice , Mice, Inbred C57BL/genetics , Mice, Transgenic/genetics , Motor Activity/physiology , Motor Activity/radiation effects , Phenotype , Proto-Oncogene Proteins c-fos/metabolism , Reference Values , Retinal Degeneration/genetics , Retinal Degeneration/physiopathology , Retinal Ganglion Cells/metabolism , Suprachiasmatic Nucleus/metabolism , Vasoactive Intestinal Peptide/metabolism
6.
Cell Tissue Res ; 283(2): 335-8, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8593663

ABSTRACT

The 'nicotinamide adenine dinucleotide phosphate diaphorase' histochemical technique was used as a marker of neuronal nitric oxide synthase to assess the presence of the enzyme in the anterior hypothalamus of the rat. Particular attention was focused on the subparaventricular zone, periventricular area and suprachiasmatic nucleus. The results show that there is strong staining in the anterior hypothalamus particularly in the subparaventricular zone by the perinuclear regions of the suprachiasmatic nucleus, and in the periventricular nucleus. Some diaphorase activity was also seen within the suprachiasmatic nucleus, but this was much weaker than in the surrounding areas. These results, taken together with existing evidence, would further suggest the involvement of nitric oxide in the signal transduction pathway in the suprachiasmatic nucleus.


Subject(s)
Hypothalamus, Anterior/enzymology , NADPH Dehydrogenase/analysis , Nerve Tissue Proteins/analysis , Suprachiasmatic Nucleus/enzymology , Animals , Biomarkers , Circadian Rhythm/physiology , Male , Nitric Oxide/biosynthesis , Rats , Rats, Sprague-Dawley , Suprachiasmatic Nucleus/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...